Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Grifols SA

Grifols SA (GRF SM)

77
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
15 Jul 2025 10:37

Liquid Universe of European Ordinary and Preferred Shares: July '25 Report

Since mid-June, share price spreads have generally widened across the European liquid universe of ordinary and preferred shares, with 6 tightening...

Share
bullishGrifols SA
11 Jul 2025 11:57

Grifols SA - Strategic Deleveraging & R&D Surge Can Power a Bullish Rebound!

The key drivers of this revenue growth included progress in the immunoglobulin franchise, which grew 17.5%, along with improvements in the...

Logo
412 Views
Share
bullishGrifols SA
16 Apr 2025 10:43

Liquid Universe of European Ordinary and Preferred Shares: April '25 Report

Since mid-March, with sessions of massive volatility, share-price spreads have generally tightened across European liquid universe of ordinary and...

Share
bullishGrifols SA
02 Apr 2025 21:30

Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield

​Brookfield's renewed interest in Grifols signals confidence in its turnaround, with strengthened financials and potential for improved future...

Share
bullishGrifols SA
12 Dec 2024 23:17

Grifols: Activism and Debt Refinancing

​Grifols strengthens liquidity through debt refinancing, faces activist shareholder pressure for governance reforms, and presents a valuation...

Share
x